BP
ABBV icon

BNP Paribas’s AbbVie ABBV Stock Holding History

BNP Paribas’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.9M Sell
68,278
-9,992
-13% -$2.22M 0.47% 45
2025
Q4 		$17.9M Buy
78,270
+30,139
+63% +$6.87M 0.51% 38
2025
Q3 		$11.1M Buy
48,131
+11
+0% +$2.24K 0.34% 55
2025
Q2 		$8.93M Buy
48,120
+338
+0.7% +$62.8K 0.29% 68
2025
Q1 		$10M Sell
47,782
-33
-0.1% -$6.42K 0.41% 58
2024
Q4 		$8.49M Buy
47,815
+1,755
+4% +$323K 0.05% 59
2024
Q3 		$9.09M Sell
46,060
-1,430
-3% -$267K 0.38% 53
2024
Q2 		$8.15M Sell
47,490
-3,780
-7% -$626K 0.41% 52
2024
Q1 		$9.33M Buy
+51,270
New +$8.84M 0.44% 52

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BNP Paribas's ABBV Position: Q1 2026 in Review

BNP Paribas reduced its AbbVie (ABBV) stake by 13% in Q1 2026, selling an estimated $2.22M and leaving 68,278 shares worth $14.9M. The position accounts for 0.47% of the portfolio, ranked #45.

BNP Paribas first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. The position peaked at $17.9M in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • BNP Paribas held 68,278 shares of AbbVie worth $14.9M as of Q1 2026.
  • BNP Paribas sold 9,992 AbbVie shares in Q1 2026, an estimated $2.22M.
  • AbbVie made up 0.47% of BNP Paribas's portfolio in Q1 2026, its #45 holding.
  • BNP Paribas first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
  • BNP Paribas's AbbVie position peaked at $17.9M in Q4 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on BNP Paribas's 13F filing for Q1 2026, filed 12 May 2026.